BICO Group AB buy Max1111
Start price
17.07.23
/
100%
€3.83
Target price
17.07.25
€20.00
Performance (%)
2.27%
Price
16:12
€3.91
Summary
This prediction is currently active. The BUY prediction by Max1111 shows slight gains of 2.27%. This prediction currently runs until 17.07.25. The prediction end date can be changed by Max1111 at any time. Max1111 has 100% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
BICO Group AB | -7.529% | -7.529% | 3.557% |
iShares Core DAX® | 1.560% | 4.721% | 18.671% |
iShares Nasdaq 100 | 0.517% | 1.171% | 23.619% |
iShares Nikkei 225® | 1.730% | 6.073% | 16.253% |
iShares S&P 500 | 1.482% | 1.218% | 23.290% |
According to Max1111 what are the pros and cons of BICO Group AB for the foreseeable future?
Pros
EBIT growth > 30% per year expected
Capable Management
Strong uniques
High Investments for future growth
Revenue growth > 30% per year expected
Leading role in innovation
Growths much faster than the competition
Market Leader or Top 3
Known brand
Very Future proof/growth oriented business model
Cons
Increased challenges to pay loans and raise capital
Risky balance sheet
ROE lower than 10% per year
Comments by Max1111 for this prediction
In the thread Cellink Ab diskutieren
Kursziel gesetzt auf 20,0
Führend im Bioprinting; 10 % Beteiligung von Sartorius<; momentan noch nicht Profitabel.
DYOR
https://bico.com/
DYOR
https://bico.com/